期刊文献+

不同中药单体成分对两性霉素B耐药的烟曲霉抑菌活性的体外研究 被引量:4

In vitro study on anti-fungal activity of different kinds of chinese herbal monomers against amphotericin B resistant aspergillus fumigatus
下载PDF
导出
摘要 目的研究4种中药单体成分对两性霉素B(AMB)耐药的烟曲霉菌的体外抗真菌效果,为进一步开发能抑制耐药烟曲霉的新药奠定研究基础。方法采用微量液基稀释法测出肉桂醛、柠檬醛、绿原酸、黄芩苷对9株临床分离的耐药烟曲霉菌的最低抑菌浓度(MIC)和最低杀真菌浓度(MFC)进行实验。结果肉桂醛对两性霉素B耐药的烟曲霉的MIC50、MIC90、MFC50和MFC90分别为128μg/ml、256μg/ml、256μg/ml和1 024μg/ml,柠檬醛对两性霉素B耐药的烟曲霉的MIC50、MIC90、MFC50和MFC90分别为256μg/ml、512μg/ml、512μg/ml和>1 024μg/ml,绿原酸、黄芩苷对两性霉素B耐药的烟曲霉的MIC50、MIC90、MFC50和MFC90均为>1 024μg/ml。结论肉桂醛、柠檬醛对AMB耐药的烟曲霉有抗真菌作用,绿原酸和黄芩苷在体外对AMB耐药的烟曲霉无抗真菌活性。 Objective To study the anti-fungal activity of four kinds of chinese herbal monomers against amphotericin B (AMB) resistant aspergillus fumigatus in vitro,in order to explore new drug which could inhibit the drug resistance of aspergillus fumigatus. Methods Susceptibility test was done with 9 clinical isolations of drug resistant aspergillus fumigatus,and the MIC and MFC on aspergillus fumigatus were determined. Results MIC50,MIC90,MFC50 and MFC90 of Cinnamaldehyde were 128ug/ml, 256ug/ml, 256ug/ml and 1 024ug/ml, respectively. MIC50, MIC90, MFC50 and MFC90 of Citral were 256ug/ml, 512ug/ml, 512ug/ml and more than 1024ug/ml respectively. MIC50, MIC90, MFC50 and MFC90 of Chlorogenic acid and Baicalin were all more than 1 024ug/ml. Conclusion Cinnamaldehyde and Citral have anti-fungal activity against AMB-resistant aspergillus fumigatus, and Cinnamaldehyde is more effective than Citral. Isochlorogenic acid and Baicalin have no anti-fungal activity against AMB- resistant aspergillus fumigatus.
出处 《中国现代医药杂志》 2014年第2期1-4,共4页 Modern Medicine Journal of China
基金 国家自然科学基金(编号:81260002) 广西教育厅面上项目(编号:200710MS156)
关键词 烟曲霉 耐药 中药单体成分 Aspergillus fumigatus Drug resistance Chinese herbal monomers
  • 相关文献

参考文献10

二级参考文献49

共引文献83

同被引文献72

  • 1林炳承,秦建华.微流控芯片实验室[J].色谱,2005,23(5):456-463. 被引量:51
  • 2韩庆雪,闻建平,冯国龙.麦角固醇工业化提取工艺研究[J].河北化工,2007,30(2):42-43. 被引量:12
  • 3龙凯,谢小梅,方建如,旷雅舒.肉桂醛、柠檬醛对烟曲霉色素及关键基因alb1 mRNA表达的影响[J].微生物学通报,2007,34(3):541-544. 被引量:12
  • 4Thompson GR, Patterson TF. Pulmonary aspergillosis .. re-cent advances[J].Semin Respir Crit Care Med, 2011,32 (6) :673-681.
  • 5Seidler MJ, Salvenmoser S, Muller FM. Aspergillus fu- migatus forms biofilms with reduced antifungal drug sus ceptibility on bronchial epithelial cells[J]. Antimicrob A- gents Chemother, 2008,52 (11) : 4130-4136.
  • 6Zhang H, Zhou W,Zhang W,et al. Inhibitory effects of citral,cinnamaldehyde,and tea polyphenols on mixed bio- film formation by foodborne staphylococcus aureus and Salmonella enteritidis[J]. J Food Prot, 2014,77 ( 6 ) : 927 933.
  • 7Khan MS,Ahmad I. Antibiofilm activity of certain phyto- compounds and their synergy with fluconazoie against Candida albicans biofilms[J]. J Antimicrob Chemother, 2012,67(3) .. 618-621.
  • 8Mowat E,Butcher J,Lang S,et al. Development o~ a sim- ple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus[J]. J Med Microhiol,2007,56(Pt 9):1205-1212.
  • 9Singhal D, Baker L, Wormald P J, et al. Aspergillus fumig- atus biofilm on primary human sinonasal epithelial culture [J]. Am J Rhinol Allergy,2011,25(4) :219-225.
  • 10Moen MD, Lyseng-Williamson KA, Scott LJ. Liposomal am photericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections[J]. Drugs,2009,69(3) :361-392.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部